Artificial intelligence virtual cells as a new paradigm in nephrology: from multiomics integration to clinical translation

Kidney diseases remain heterogeneous and mechanistically complex, and current experimental models only partially capture patient-specific dynamics.We advance artificial-intelligence virtual cells (AIVCs) as a translational framework that learns cross-modal representations of renal cell states, performs high-throughput in silico perturbations, and improves via experiment-in-the-loop updates with organoid and real-world readouts.We outline a methodological pathway-data, representation, intervention, evaluation, deployment-anchored to atlas-grade tissue references (e.g., Kidney Precision Medicine Project) and complementary Human Cell Atlas resources, paired molecular-clinical cohorts, and minimally invasive urinary modalities to enable longitudinal, patient-centered modeling.AIVCs complement physical cells: molecular signals are harmonized into uncertainty-calibrated latent states; counterfactual simulations explore dose-time-context responses; and multicellular interactions are formalized as testable niche dynamics.To address competence and trust, we adopt a risk-proportionate verification-validation-uncertainty perspective aligned with contemporary guidance, emphasizing multisite external validation, counterfactual validity on held-out perturbations, probabilistic calibration with decision utility, and subgroup fairness auditing.Clinically, we map opportunities across mechanism reconstruction, individualized treatment-response prediction, nephrotoxicity triage, trial emulation, and routes toward kidney digital twins.Finally, we propose a practical AIVC-organoid partnership-simulate experiment validate iterate-to prioritize hypotheses, shrink the experimental search space, and link mechanistic evidence to bedside decisions.By integrating representation learning, virtual experimentation, and continual updating with interoperable data standards and governance, AIVCs offer an actionable roadmap for precision nephrology.

Authors

Institutions

Publication Details

Journal
Kidney Research and Clinical Practice
Published
2026-02-13
DOI
https://doi.org/10.23876/j.krcp.25.316
Primary Topic
Renal and related cancers
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Artificial intelligence virtual cells as a new paradigm in nephrology: from multiomics integration to clinical translation

Yongzheng Hu, Xinyue Qi, Wei Jiang, Yabin Wang
Kidney Research and Clinical Practice
Renal and related cancers
article

Artificial intelligence virtual cells as a new paradigm in nephrology: from multiomics integration to clinical translation

Yongzheng Hu, Xinyue Qi, Wei Jiang, Yabin Wang
article en

Abstract

Kidney diseases remain heterogeneous and mechanistically complex, and current experimental models only partially capture patient-specific dynamics.We advance artificial-intelligence virtual cells (AIVCs) as a translational framework that learns cross-modal representations of renal cell states, performs high-throughput in silico perturbations, and improves via experiment-in-the-loop updates with organoid and real-world readouts.We outline a methodological pathway-data, representation, intervention, evaluation, deployment-anchored to atlas-grade tissue references (e.g., Kidney Precision Medicine Project) and complementary Human Cell Atlas resources, paired molecular-clinical cohorts, and minimally invasive urinary modalities to enable longitudinal, patient-centered modeling.AIVCs complement physical cells: molecular signals are harmonized into uncertainty-calibrated latent states; counterfactual simulations explore dose-time-context responses; and multicellular interactions are formalized as testable niche dynamics.To address competence and trust, we adopt a risk-proportionate verification-validation-uncertainty perspective aligned with contemporary guidance, emphasizing multisite external validation, counterfactual validity on held-out perturbations, probabilistic calibration with decision utility, and subgroup fairness auditing.Clinically, we map opportunities across mechanism reconstruction, individualized treatment-response prediction, nephrotoxicity triage, trial emulation, and routes toward kidney digital twins.Finally, we propose a practical AIVC-organoid partnership-simulate experiment validate iterate-to prioritize hypotheses, shrink the experimental search space, and link mechanistic evidence to bedside decisions.By integrating representation learning, virtual experimentation, and continual updating with interoperable data standards and governance, AIVCs offer an actionable roadmap for precision nephrology.

Kidney Research and Clinical Practice
Qingdao University (CN), Affiliated Hospital of Qingdao University (CN)
Qingdao Key Health Discipline Development Fund, National Natural Science Foundation of China
Openalex Percentile: Top 58%
Renal and related cancers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.